Multicenter, national/international, prospective/retrospective, observational study.
start of the project: 08/2025
Primary Objective:
To collect epidemiological and clinical data and to monitor the course of treatment in patients diagnosed with bladder cancer.
Secondary Objectives:
To evaluate the effectiveness of the observed treatment and therapeutic regimens used.
To monitor the various types of treatment administered, including radiotherapy and surgical procedures.
To assess patient survival in relation to the monitored clinical factors.
To evaluate treatment sequence strategies, time to progression, and overall survival.
To assess the safety of the observed treatment.
Expert Guarantee
Czech Society for Oncology of the Czech Medical Association of J. E. Purkyně
The registry is supervised by prof. Alexandr Poprach, MD, Ph.D.
Project Management
Institute of Biostatistics and Analyses, Ltd., a spin-off company of Masaryk University, ensures management and other service activities for this project.
PharmDr. Kateřina Staňková, Project Manager
Ing. Petr Brabec, Ph.D., Managing Director
- Anaesthesiology, intensive care medicine
- Cardiology, angiology
- Diabetology, dietetics
- Educational projects
- Emergency medicine, toxicology
- Endocrinology, metabolism
- Gastroenterology, hepatology
- Haematology, haematological oncology
- Immunology, allergology
- Medical genetics
- Nephrology
- Neurology, neurosurgery
- Nursing care
- Obstetrics, gynaecology
- Oncology, radiotherapy
- Ophthalmology
- Paediatrics, neonatology
- Pathology, laboratory medicine
- Pulmonary medicine
- Rheumatology, physiotherapy
- Screening programmes
- Surgery, traumatology, orthopaedics
- Urology